Camella is a Vice President at Northpond Ventures, a science-driven venture capital firm with a mission to build a better tomorrow. She leverages her experiences across academic research, management consulting, and venture capital to invest in and support bold entrepreneurs building solutions at the intersection of Life Sciences, Healthcare, and Technology. Camella focuses on precision medicine approaches for chronic disease and advanced computational and software tools for healthcare applications. Camella is passionate about investing in technologies and business models that make a difference, especially those that positively impact human health, well-being, and longevity. Dr. Wilson holds a Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania.